Ovarian Stimulation Outcomes During a GnRH Antagonist Protocol for In-vitro Fertilization When Comparing Trigger Day Decision by Physicians Versus an Artificial Intelligence-based Algorithm.

ConditionIVF Outcomes

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-45

SponsorFertilAI

About this trial

To compare the number of mature oocytes following a GnRH antagonist in-vitro fertilization stimulation cycle when comparing trigger day timing decision by physicians versus an artificial intelligence-based algorithm

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All patients undergoing an ovarian stimulation cycle utilizing the GnRH antagonist protocol for oocyte cryopreservation or for fertilization via intracytoplasmic sperm injection (ICSI) (any treatment where oocytes are denuded and maturity may be assessed).

Disqualifiers

Loss to follow-up, patient retracts consent to participate

Trial design

Design model

Parallel

Treatments tested in this trial

Artificial intelligence-based algorithm
Other intervention
Trigger day timing decision by an artificial intelligence-based algorithm

Treatment groups

180 Participants

are divided into 2 treatment groups

Group A: Physician-based trigger day timing decisionNo intervention 0 interventions

Group B: Artificial intelligence-based algorithm trigger day timing decisionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

Mature oocyte yield

The number of mature oocytes collected during a single egg retrieval cycle

Time frame

2 years

Secondary outcomes

Oocyte yield

Number of retrieved oocytes during an egg collection cycle

Time frame

2 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

FertilAI

Lead sponsor

Source ClinicalTrials.gov

Apply now